(+)‐Hydrastine is a phthalide isoquinoline alkaloid, isolated from Corydalis stricta. It has the same 1S,9R configuration as the competitive GABAA receptor antagonist bicuculline and is the enantiomer of the commercially available (−)‐hydrastine.
(+)‐Hydrastine (CD50 0.16 mg kg−1, i.v.) was twice as potent as bicuculline (CD50 0.32 mg kg−1, i.v.) as a convulsant in mice. This action was stereoselective in that (+)‐hydrastine was 180 times as potent as (−)‐hydrastine.
(+)‐Hydrastine was a selective antagonist at bicuculline‐sensitive GABAA receptors in the guinea‐pig isolated ileum. It did not influence phaclofen‐sensitive GABAB receptors or acetylcholine receptors in this tissue. (+)‐Hydrastine was a competitive antagonist of GABAA responses (pA2 6.5) more potent than bicuculline (pA2 6.1).
When tested against the binding of [3H]‐muscimol to high affinity GABAA binding sites in rat brain membranes, (+)‐hydrastine (IC50 2.37 μm) was 8 times more potent than bicuculline (IC50 19.7 μm).
As an antagonist of the activation of low affinity GABAA receptors as measured by the stimulation by GABA of [3H]‐diazepam binding to rat brain membranes, (+)‐hydrastine (IC50 0.4 μm) was more potent than bicuculline (IC50 2.3 μm).
(+)‐Hydrastine, 10 nm to 1 mm, did not inhibit the binding of [3H]‐(−)‐baclofen to GABAB binding sites in rat brain membranes.